OnKure Therapeutics, Financials
| OKUR Stock | 8.38 0.33 4.10% |
OnKure |
OnKure Therapeutics, Stock Summary
OnKure Therapeutics, competes with Dogwood Therapeutics,, Opus Genetics,, and Telix Pharmaceuticals. OnKure Therapeutics, is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Healthcare, Biotechnology |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 75974E103 68277Q105 |
| Older Symbol | RPHM |
| Location | California; U.S.A |
| Business Address | 6707 Winchester Circle, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | onkuretherapeutics.com |
| Phone | 720 307 2892 |
OnKure Therapeutics, Key Financial Ratios
| Net Income | (35.31 M) | ||||
| Total Asset | 35.73 M | ||||
| Retained Earnings | (102.05 M) |
OnKure Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining OnKure Therapeutics,'s current stock value. Our valuation model uses many indicators to compare OnKure Therapeutics, value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across OnKure Therapeutics, competition to find correlations between indicators driving OnKure Therapeutics,'s intrinsic value. More Info.OnKure Therapeutics, is regarded fifth in net income category among its peers. It is rated top company in total debt category among its peers . OnKure Therapeutics, reported last year Net Loss of (35.31 Million). Comparative valuation analysis is a catch-all technique that is used if you cannot value OnKure Therapeutics, by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.OnKure Therapeutics, Systematic Risk
OnKure Therapeutics,'s systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. OnKure Therapeutics, volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on OnKure Therapeutics, correlated with the market. If Beta is less than 0 OnKure Therapeutics, generally moves in the opposite direction as compared to the market. If OnKure Therapeutics, Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one OnKure Therapeutics, is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of OnKure Therapeutics, is generally in the same direction as the market. If Beta > 1 OnKure Therapeutics, moves generally in the same direction as, but more than the movement of the benchmark.
OnKure Therapeutics, December 21, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of OnKure Therapeutics, help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of OnKure Therapeutics,. We use our internally-developed statistical techniques to arrive at the intrinsic value of OnKure Therapeutics, based on widely used predictive technical indicators. In general, we focus on analyzing OnKure Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build OnKure Therapeutics,'s daily price indicators and compare them against related drivers.
| Information Ratio | (0.21) | |||
| Maximum Drawdown | 20.82 | |||
| Value At Risk | (8.47) | |||
| Potential Upside | 5.88 |
Additional Tools for OnKure Stock Analysis
When running OnKure Therapeutics,'s price analysis, check to measure OnKure Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OnKure Therapeutics, is operating at the current time. Most of OnKure Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of OnKure Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OnKure Therapeutics,'s price. Additionally, you may evaluate how the addition of OnKure Therapeutics, to your portfolios can decrease your overall portfolio volatility.